Skip to content

The Effect of Intracoronary Adenosine Injection on Outcomes of Primary Percutaneous Intervention in Patients with ST-segment Elevation Myocardial Infarction

The Effect of Intracoronary Adenosine Injection on Outcomes of Primary Percutaneous Intervention in Patients with ST-segment Elevation Myocardial Infarction; A randomized controlled clinical trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220809055645N6
Enrollment
120
Registered
2023-06-07
Start date
2023-06-20
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute transmural myocardial infarction of unspecified site. ST elevation (STEMI) myocardial infarction of unspecified site

Interventions

Intervention 1: Intervention group: Adenosine injection. Intervention 2: Control group: No adenosine injection/routine care with 5 cc of normal saline.

Sponsors

Rasht University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Diagnosis of STEMI in the emergency department Having complete criteria for primary PCI TIMI flow grade= 0-0-1 Coronary angiography Informed consent

Exclusion criteria

Exclusion criteria: Cardiogenic shock Complete AV block Severe renal failure (serum creatinine> 3 mg/dL) Need for emergency coronary artery bypass surgery History of recurrent coronary artery disease

Design outcomes

Primary

MeasureTime frame
(Major adverse cardiac events) MACE, which in this study is a combination of cardiac death, non-fatal myocardial infarction, any re-angiogenesis and stroke, and are defined according to The Academic Research Consortium. Timepoint: Within forty days after the intervention. Method of measurement: All patients will be followed up for MACE for 40 days, either through clinic visits or telephone interviews.

Secondary

MeasureTime frame
No-reflow phenomenon refers to the lack of blood flow after coronary artery reopening. Timepoint: before and immediately after primary angioplasty. Method of measurement: based on angiographic criteria such as TIMI flow grade and TIMI frame count.;ST-segment resolution (STR) is considered if the ST segment returns more than 70% to the isoelectric line 90 minutes after injection. Timepoint: before and 90 minutes after intervention. Method of measurement: Standard 12-lead ECG will be taken from all patients at hospital admission and 90 minutes after PPCI. The sum of ST segment elevation, 20ms after the J point in all leads will be recorded. After calculating the total increase in ST-segment elevation in leads representing the infarct location on the baseline ECG and at minute 90, STR will be expressed as a percentage by dividing the second number by the first number and subtracting it from 100.;Left ventricular ejection fraction (LVEF) refers to how well the left ventricle pumps blood with each contraction. Timepoint: Before the intervention and 40 days after the intervention. Method of measurement: By a cardiologist with an echocardiography device using the Biplaine Simpson method, then the percentage of LVEF recovery will be calculated as the difference between the initial LVEF and 40 days later.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Baharvand

Rasht University of Medical Sciences

dr.baharcardio@gmail.com+98 13 3366 4282

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026